Diagnostic and Therapeutic Endoscopy, Vol. 7, pp. 29-33Reprints available directly from the publisherPhotocopying permitted by license only
(C) 2000 OPA (Overseas Publishers Association) N.V.Published by license under
the Harwood Academic Publishers imprint,part of The Gordon and Breach Publishing Group.
Printed in Malaysia.
Percutaneous Dye Image Cardioscopy for Detectionof Endocardial Lesions
MASAHITO KANAIa’*, TAKESHI SAKURAIa, KUNIO YOSHINAGAa, KANEYUKI AOYAGIa,TAKASHI HITSUMOTOa, MASAKI YOSHINUMAa, TAKASHI UCHIa, HIROFUMI NOIKEa,
HIDEFUMI OHSAWAa, KOUHEI KAWAMURAa, KEIICHI TOKUHIRO, MAKIKO TAKAHASHIb,TADASHI EBIHARAb, KEIICHI TACHIHARAb and YASUMI UCHIDA
aCardiovascular Center, bClinical Engineering Toho University Hospital at Sakura,564 Shioshizu, Sakura-shi, Chiba 285-0841, Japan
(Received 3 May 2000; Revised 15 June 2000; In finalform 15 June 2000)
Endocardial lesions are caused not only by inflammatory processes but also by myocardialischemia, resulting in endocardial thrombosis and cerebral embolism. We deviced a methodfor direct visualization of endocardial damages by a novel dye image cardioscopy withEvans blue and examined its feasibility in patients with heart disease. The dye was injectedinto the left ventricle before and after endomyocardial biopsy. Endocardial surface wasstained in dark blue in 63% of patients with angina pectoris before biopsy. After biopsy,the biopsied portions were stained in blue in all. The results indicate that endocardium isdamaged even in apparently intact LV in patients with ischemic heart disease and thatendomyocardial biopsy causes severe endocardial damages.
Keywords: Endocardial damage, Evans blue dye, Ischemic heart disease, Percutaneouscardioscopy, Vital staining
INTRODUCTION
In 1976, Uchida reported a original percutaneouscardioscopic technique, and the clinical applica-tion of the cardioscopy was started in 1987. Sincethen, percutaneous cardioscopy enabled percuta-neous observation of the interior of the heartfor a macroscopic pathologic diagnosis of theheart disease [1-3]. Clinically, there is a specific
syndrome "Cardiocerebral Syndrome" in whichcerebral attack occures following cardiac attack(acute myocardial infarction). It is generallybelieved that thrombus formed in the heart isdetached and flows into the cerebral arteries,resulting in this syndrome. However, the pro-cess of thrombus formation on the endocardiumof the ischemic region of the heart is not wellknown.
* Corresponding author. Tel.: / 81-43-462-8811, ext. 2215. Fax: / 81-43-487-4246.
29
30 M. KANAI et al.
Extensive myocardial infarction causes left ven-tricular contraction disturbance and stagnation ofblood. This stagnation is believed to be the maincause of thrombus formation. Recent cardioscopicexamination revealed frequent mural thrombus inthe left ventricle without obvious contraction dis-turbance [4]. This fact suggests that blood stagna-tion is not the sole cause of thrombus formation.There is a possibility that endocardial cells whichact against thrombus formation are damageddue to myocardial ischemia resulting in thrombusformation. Therefore, we attempted whether ornot endocardial damages exist in patients withischemic heart disease.
Discrimination of endocardial cell damages arebeyond conventional cardioscopes. We found thatEvans blue dye which selectively stains endothelialcells of the cardiovascular systems. Therefore, weperformed dye image cardioscopy in patients withischemic heart disease.
SUBJECTS AND METHODS
Cardioscope system
The cardioscope system was composed of a thin5F fiberscope (Olympus Co, LTD, Tokyo, Japan)and a 9F guiding balloon catheter (Fig. 1).The fiberscope was connected to a CCD cameraand an illumination source (Xenon lamp). Theobtained images were displayed through a videoconverter simultaneously with X-ray images ona 14-inch video monitor and were recorded on avide tape.
Subjects
Thirty-five patients with heart disease (16 ptswith angina pectoris (AP), 11 with dilated cardio-myopathy (DCM) and 8 pts with chest pain syn-drome (CPS)) underwent percutaneous dye image
FIGURE Cardioscope used in this study. (A) fiberscope 5F (Olympus Co. Ltd., Tokyo, Japan) (B) balloon (C) shaft.
DYE IMAGE CARDIOSCOPY 31
cardioscopy after the routine cardiac catheteriza-tion. Because of the experimental nature, informedconsent for percutaneous dye image cardioscopywas obtained from all patients.
Procedures
After the routine catheterization and angiogra-phy, a guiding balloon catheter was introduced,through the sheath previously introduced into theright femoral artery, into the left ventricle. Theballoon was inflated with CO2. Then, a 5F fiber-scope was introduced through the catheter so as tolocate its tip at the distal most tip of catheter. Theinflated balloon was pushed against the left ven-tricular wall. Heparinized saline was infused at arate of 3-5 ml/sec for several seconds by a powerinjector for observation. Thereafter, ml of Evansblue dye solution (20mg/ml saline solution) was
directly injected through the guiding catheter intothe left ventricle.
RESULTS
Figure 2 shows the endocardial surface in a patientwith angina pectoris. The surface was apparentlyintact before staining. After staining, however, thesurface was stained in dark blue.
Figure 3 shows the edges of the trabeculae in a
patient with angina pectoris. The edges were whitein color before staining. After staining, the edgeswere stained in dark blue.
Figure 4 shows the edges of the trabeculae ina patient with dilated cardiomyopathy. The edgesof trabeculae were atrophic and yellow in colorbefore biopsy. After biopsy, the biopsied portionwas extensively stained in dark blue.
FIGURE 2 47-year-old female with angina pectoris. (A) The endocardial surface was brown in color before staining. (B) Thesurface was stained in dark blue with Evans blue.
32 M. KANAI et al.
FIGURE 3 69-year-old male with angina pectoris. (A) The edge of trabecle was white in color before staining. (B) The endocardialsurface was stained in dark blue with Evans blue.
TABLE Endocardial staining with evans blue dye
Before biopsy After biopsy
AP 10/16 (63%) 4/4 (100%)DCM 8/11 (73%) 6/6 (100%)C’S 3/8 (38%) / (00%)
AP: angina pectoris, DCM: Dilated cardiomyopathy. CPS:Chest pain syndrome.
Thus, endocardium was stained in 63% ofpatients with angina pectoris. Especially, the edgesof the trabeculae were strongly stained. Afterbiopsy, the biopsied portions were extensivelystained (Table I).
FIGURE 4 44-year-old male with dilated cardiomyopathy.(A) The trabecle (arrow) was atrophic and yellow in colorbefore biopsy. (B) The endocardium and thrombus (arrow)were stained in dark blue after biopsy.
DISCUSSION
Recent advances in fiberscope and guiding systemtechnology enabled us to perform a percutaneousobservation of the luminal changes of the cardio-vascular systems [5-8]. However, the conventionalcardioscope could not allow discrimination of finecomposition of the target. It was beyond the abil-ity of conventional cardioscope for differentiation
DYE IMAGE CARDIOSCOPY 33
of the cardiovascular changes of cellular order.Therefore, to observe vascular luminal changesof cellular order, an intravascular microscopewas devised, and its feasibility was examined. Theluminal changes observed by the microscopecorrelated well with histologic changes [9-10].Furthermore, structures of human vascular lesionsof cellular order could be observed percutaneouslyby the intravascular microscope [11].However, the microscope is composed of a rigid
rod lens but not of flexible thin glass fibers, and itslength is short. Therefore application to the heartis impossible. In this study, in order to discriminateendocardial changes of cellular order, we devisedpercutaneous dye imaged cardioscopy. With theaid of Evans blue, endocardial damages were
clearly demonstrated.In this study, endocardial damages were fre-
quently observed in patients with angina pectorisas in case of DCM. Inflammatory process is con-sidered to be involved in DCM. In case of anginapectoris, severe ischemia may affected not onlymyocardial cells but also endocardial cells, leadingto their death and fibrosis. These otherwise notdemonstrable endocardial damages may contri-bute to mural thrombus formation, which wasnot infrequently observed in this category of heartdisease. These thrombus may participate in cause-unknown cerebral thrombo-embolic attacks.
References
[1] Uchida, Y., Fujinori, Y. and Hirose, J. Percutaneous leftventricular endomyocardial biopsy with angioscopy guid-ance in dilated cardiomyopathy. Am. Heart J. 1989; 118:1039-1041.
[2] Uchida, Y., Tomaru, T., Nakamura, F. et al. Percutaneousfiberoptic cardioscopy of the left ventricle in patients withideopatic myocarditis and dilated cardiomyopathy. Am.Heart J. 1990; 119: 949-950.
[3] Oshima, T., Hirose, J., Sasaki, T. and Uchida, Y. Cardio-scopic observation of cardiac thrombus. Circulation 1994;Supple: 50.
[4] Uchida, Y. Mural thrombus in the heart. Cardioangioscopy1995; 126-129.
[5] Uchida, Y., Tomaru, T., Nakamura, F. et al. Percutaneouscoronary angioscopy’in patients with ischemic heart dis-ease. Am. Heart J. 1987; 114: 1069-1075.
[6] Sherman, C.T., Litvak, F., Grundfest, W. et alo Coronaryangioscopy in patients with unstable angina pectoris.N. Engl. J. Med. 1989; 60:913-919.
[7] Ramee, S.R., White, J.C., Collins, T.J. et al. Percutaneousangioscopy during angioplasty using a steerable microan-gioscopy. J. Am. Coll. Cardio. 1991; 17: 100-105.
[8] Uchida, Y., Fujinori, Y., Tomaru, T. et al. Percutaneousangioplasty of chronic obstruction of peripheral arteries bya temperature-controlled Nd:YAG laser system. J. Inter-vent Cardiol. 1992; 5: 301-308.
[9] Uchida, Y., Tomaru, T., Kamijo, To et al. Comparativestudies on transluminal angiomicroscopic and ex vivomicroscopic features of vascular lesions. SPIE 1992;1642:217-220.
[10] Tomaru, T., Uchida, Y., Nakamura, F. et al. Transluminalangio-microscopy of arterial thrombus and thrombolysis.SPIE 1992; 1642:214-216.
[11] Uchida, Y., Nakamura, F. and Morita, T. Observation ofatherosclerotic lesions by an intravascular microscope inpatients with arteriosclerosis obliterans. Am. Heart J. 1995;130: 1114-1119.
Submit your manuscripts athttp://www.hindawi.com
Stem CellsInternational
Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014
Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014
MEDIATORSINFLAMMATION
of
Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014
Behavioural Neurology
EndocrinologyInternational Journal of
Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014
Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014
Disease Markers
Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014
BioMed Research International
OncologyJournal of
Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014
Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014
Oxidative Medicine and Cellular Longevity
Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014
PPAR Research
The Scientific World JournalHindawi Publishing Corporation http://www.hindawi.com Volume 2014
Immunology ResearchHindawi Publishing Corporationhttp://www.hindawi.com Volume 2014
Journal of
ObesityJournal of
Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014
Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014
Computational and Mathematical Methods in Medicine
OphthalmologyJournal of
Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014
Diabetes ResearchJournal of
Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014
Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014
Research and TreatmentAIDS
Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014
Gastroenterology Research and Practice
Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014
Parkinson’s Disease
Evidence-Based Complementary and Alternative Medicine
Volume 2014Hindawi Publishing Corporationhttp://www.hindawi.com